Q1 2024 Holdings
Filed 2024-05-15 | 35 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $177.1M | 182,536 | 12.2% |
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $162.5M | 3,880,230 | 11.2% |
| Salesforce Inc(CRM) | COM | 79466L302 | $144.6M | 480,160 | 10.0% |
| Edgewise Therapeutics Inc(EPC) | COM | 28035Q102 | $115.7M | 6,344,430 | 8.0% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $60.7M | 2,411,362 | 4.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $57.7M | 845,000 | 4.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $51.4M | 1,098,600 | 3.5% |
| Cable One Inc(CABO) | COM | 12685J105 | $50.1M | 118,403 | 3.5% |
| Lanzatech Global Inc | COM | 51655R101 | $48.9M | 15,814,845 | 3.4% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $44.6M | 1,400,000 | 3.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $39.3M | 450,000 | 2.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $37.7M | 1,500,000 | 2.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $36.3M | 1,339,304 | 2.5% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $36.2M | 500,827 | 2.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $34.0M | 358,626 | 2.3% |
| Apple Inc(AAPL) | COM | 037833100 | $31.4M | 182,960 | 2.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $29.5M | 2,500,000 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $28.3M | 1,050,000 | 2.0% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $27.9M | 1,250,000 | 1.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $27.0M | 1,168,030 | 1.9% |
| Verve Therapeutics Inc | COM | 92539P101 | $26.6M | 2,000,000 | 1.8% |
| Brookfield Asset Managmt LTD(BAM) | CL A LMT VTG SHS | 113004105 | $26.4M | 627,207 | 1.8% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $25.7M | 1,638,298 | 1.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $19.3M | 1,100,000 | 1.3% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $19.2M | 1,077,140 | 1.3% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $18.3M | 1,739,175 | 1.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $17.7M | 118,383 | 1.2% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $17.4M | 700,000 | 1.2% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $14.1M | 65,524 | 1.0% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $8.8M | 5,088,258 | 0.6% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $5.1M | 1,126,915 | 0.4% |
| Treace MED Concepts Inc(TMCI) | COM | 89455T109 | $4.7M | 360,000 | 0.3% |
| Marqeta Inc(MQ) | CLASS A COM | 57142B104 | $2.6M | 441,558 | 0.2% |
| Galecto Inc(GLTOUSD) | COM | 36322Q107 | $1.9M | 2,497,791 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $806.5K | 468,902 | 0.1% |